{"Symbol": "ABBV", "AssetType": "Common Stock", "Name": "AbbVie Inc", "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.", "CIK": "1551152", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "205498368000", "EBITDA": "28854999000", "PERatio": "27.7", "PEGRatio": "1.279", "BookValue": "7.67", "DividendPerShare": "5.2", "DividendYield": "0.0444", "EPS": "4.196", "RevenuePerShareTTM": "31.19", "ProfitMargin": "0.137", "OperatingMarginTTM": "0.367", "ReturnOnAssetsTTM": "0.0848", "ReturnOnEquityTTM": "0.523", "RevenueTTM": "55168999000", "GrossProfitTTM": "31747000000", "DilutedEPSTTM": "4.196", "QuarterlyEarningsGrowthYOY": "0.38", "QuarterlyRevenueGrowthYOY": "0.112", "AnalystTargetPrice": "128.32", "TrailingPE": "27.7", "ForwardPE": "8.45", "PriceToSalesRatioTTM": "3.725", "PriceToBookRatio": "15.27", "EVToRevenue": "4.993", "EVToEBITDA": "15.06", "Beta": "0.799", "52WeekHigh": "120.07", "52WeekLow": "96.44", "50DayMovingAverage": "110.98", "200DayMovingAverage": "111.94", "SharesOutstanding": "1767880000", "DividendDate": "2022-02-15", "ExDividendDate": "2022-01-13"}